Skip to main content
Clinical Trials/CTRI/2019/07/020104
CTRI/2019/07/020104
Completed
Phase 2

A Randomised Controlled Clinical Trial to evaluate efficacy of Yonidhoopan by Bruhatiphal-Haridradway in management of Yonikandu in relation to Vulvovaginitis.

All India Institute of Ayurveda0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: N768- Other specified inflammation of vagina and vulva
Sponsor
All India Institute of Ayurveda
Enrollment
60
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 27, 2020
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Married woman
  • Age 20 to 40 years
  • Clinical sign symptoms of vulvovaginitis that is itching pain in vulvovaginal region redness scratch marks
  • Microscopically positive specimen for Candida albicans Trichomonas Monoliasis E coli

Exclusion Criteria

  • Pregnant women
  • Immuno compromised patients
  • Suspected cases of carcinoma of cervix endometrial carcinoma
  • Known case of Asthma
  • Tuberculosis positive
  • Senile vaginitis
  • Systemic illness like Diabetes mellitus Severe Anaemia Liver disorder Hypertension

Outcomes

Primary Outcomes

Not specified

Similar Trials